Drug General Information
Drug ID
D09JGO
Former ID
DIB019533
Drug Name
compound 51
Synonyms
Ac-RLTbaLAR-H
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530373]
Structure
Download
2D MOL
Formula
C36H68N12O8
InChI
InChI=1S/C36H68N12O8/c1-19(2)16-25(30(52)43-21(5)28(50)45-24(33(55)56)13-11-15-42-35(39)40)47-32(54)27(18-36(7,8)9)48-31(53)26(17-20(3)4)46-29(51)23(44-22(6)49)12-10-14-41-34(37)38/h19-21,23-27H,10-18H2,1-9H3,(H,43,52)(H,44,49)(H,45,50)(H,46,51)(H,47,54)(H,48,53)(H,55,56)(H4,37,38,41)(H4,39,40,42)/t21-,23-,24-,25-,26-,27-/m0/s1
InChIKey
VIJSPAIQWVPKQZ-BLECARSGSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Complement Factor B Target Info Inhibitor [530373]
KEGG Pathway Complement and coagulation cascades
Staphylococcus aureus infection
NetPath Pathway TGF_beta_Receptor Signaling Pathway
Reactome Alternative complement activation
Activation of C3 and C5
Regulation of Complement cascade
WikiPathways Complement and Coagulation Cascades
Human Complement System
Complement cascade
References
Ref 530373Structure-activity relationships for substrate-based inhibitors of human complement factor B. J Med Chem. 2009 Oct 8;52(19):6042-52.
Ref 530373Structure-activity relationships for substrate-based inhibitors of human complement factor B. J Med Chem. 2009 Oct 8;52(19):6042-52.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.